Elite Pharmaceuticals Inc /DE/ - Current report filing (8-K)
25 October 2007 - 6:46AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D)
OF THE SECURITIES EXCHANGE ACT OF 1934
October 24, 2007
---------------------------
(Date of Report)
ELITE PHARMACEUTICALS, INC.
-----------------------------------------------
(Exact name of registrant as specified in its charter)
Delaware
|
333-45241
|
22-3542636
|
------------
|
-------------
|
--------------
|
(State or other jurisdiction
of incorporation)
|
(Commission
File Number)
|
(IRS Employer
Identification No.)
|
165 Ludlow Avenue, Northvale, New Jersey 07647
---------------------------------------------------------------
(Address of principal executive offices)
(201) 750-2646
---------------------
(Registrants telephone number, including area code)
The shares of common stock, par value $0.01 per share (the Common Stock), of Elite Pharmaceuticals, Inc. a Delaware corporation (the Registrant), which are listed on the American Stock Exchange, shall be eligible for the Direct Registration System effective as of November 1, 2007. On or after November 1, 2007, the Registrants common stockholders shall have the option to have physical stock certificates evidencing their share ownership or have such shares listed by book-entry on the Direct Registration System.
Stockholders of the Registrant should contact the Registrants transfer agent, Jersey Transfer and Trust Company, if they wish to have the shares listed by book-entry.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
Elite
Pharmaceuticals, Inc.
|
|
|
|
Date: October 24, 2007
|
By:
|
/s/
Bernard J. Berk
|
|
|
Bernard
J. Berk
|
|
|
Chief
Executive Officer
|
Elite Pharmaceuticals (AMEX:ELI)
Historical Stock Chart
From Jun 2024 to Jul 2024
Elite Pharmaceuticals (AMEX:ELI)
Historical Stock Chart
From Jul 2023 to Jul 2024
Real-Time news about Elite Pharmaceuticals, (American Stock Exchange): 0 recent articles
More Elite Pharmaceuticals Inc /DE/ News Articles